PPBT Stock Analysis: Buy, Sell, or Hold?
PPBT - Purple Biotech Ltd. American Depositary Shares
$4.27
-0.27 (-6.02%)
▼
5d:
-13.74%
30d:
+14.63%
90d:
+568.65%
WAIT
LOW Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: May 20, 2026
20d
Get Alerted When PPBT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PPBT is down 13.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PPBT is down 13.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PPBT is currently trading at $4.27, which is considered fair relative to its 30-day fair value range of $3.94 to $4.59.
Technical Outlook: Technically, PPBT is in a strong uptrend. Immediate support is located at $3.98, while resistance sits at $5.00. Short-term momentum is weak, with the stock down 6.0% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.00 (+560.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PPBT is in a strong uptrend. Immediate support is located at $3.98, while resistance sits at $5.00. Short-term momentum is weak, with the stock down 6.0% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.00 (+560.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.94 -
$4.59
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.0%)
- BULLISH: Trading 560.3% below Wall St target ($30.00)
- WARNING: Recommendation downgraded due to -13.7% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$3.94 -
$4.59
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.99
Resistance Level
$5.00
Current Trend
Strong Uptrend
Technical data as of
Apr 29, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.10
Wall Street Target
$30.00
(+560.3%)
Share & Embed Analysis
Last updated: April 29, 2026 1:43 PM ET
Data refreshes hourly during market hours. Next update: 2:43 PM
Data refreshes hourly during market hours. Next update: 2:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PPBT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 65 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$878 | 58 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 56 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 55 HOLD |
